Concord Medical Services Holdings Ltd CCM

Annual Quarterly

FY2025 · ended Dec 31, 2025 · Revenue $64.97M, +26.6% YoY · Filed Apr 29, 2026

Concord Medical Services Holdings Ltd (CCM) files with the SEC under industry code 8011, Services-Offices & Clinics of Doctors of Medicine. In fiscal 2025, which ended Dec 31, 2025, it reported revenue of $65.0 million and a net loss of $13.3 million. Free cash flow was -$36.9 million. As of Dec 31, 2025 it held $102.9 million in cash and investments and $578.5 million in total debt.

Revenue
$64.97M
+26.6% vs prior year
Net income
$-13.27M
+68.6% vs prior year
Operating cash flow
$-28.86M
+47.0% vs prior year
Free cash flow
$-36.91M
+50.9% vs prior year
EPS
$-0.10
+68.8% vs prior year
Dividend per share
$0.00
Shares outstanding
130.25M
+0.0% vs prior year
Net cash
$-475.55M
FY 2025
Operating margin
-57.6%
FY 2025

Company profile

Industry
Services-Offices & Clinics of Doctors of Medicine (SIC 8011)
Listed as
CCM (NYSE)
Incorporated in
Cayman Islands
Headquarters
Chaoyang District, Beijing
SEC filer status
Non-accelerated filer
SEC CIK
1472072

Other Services-Offices & Clinics of Doctors of Medicine companies

Key figures

Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.

Line
FY 2025
Dec 31, 2025
FY 2024
Dec 31, 2024
FY 2023
Dec 31, 2023
FY 2022
Dec 31, 2022
FY 2021
Dec 31, 2021
Revenue
$65.0M
$51.3M
$73.3M
$65.3M
$69.5M
Operating income
-$37.4M
-$72.9M
-$65.2M
-$76.1M
-$71.9M
Net income
-$13.3M
-$42.2M
-$41.9M
-$71.0M
-$42.6M
Diluted EPS
-$0.10
-$0.32
-$0.32
-$0.54
—
Operating cash flow
-$28.9M
-$54.5M
-$38.9M
-$31.4M
-$56.4M
Free cash flow
-$36.9M
-$75.1M
-$54.9M
-$63.7M
-$100.2M
Total assets
$936.3M
$921.5M
$852.7M
$870.6M
$977.6M
Total liabilities
$671.7M
$699.9M
$606.6M
$578.4M
$547.1M
Stockholders' equity
-$300.7M
-$312.4M
-$298.9M
-$270.3M
-$215.0M
Cash and investments
$102.9M
$112.8M
$63.8M
$86.4M
$86.0M
Total debt
$578.5M
$624.8M
$506.4M
$491.3M
$447.1M

Recent SEC filings

Recent SEC filings
Form Description Filed Period
6-K Current report (foreign issuer) Sep 22, 2026 Sep 22, 2026
6-K Current report (foreign issuer) Jul 2, 2026 Jul 2, 2026
6-K Current report (foreign issuer) May 18, 2026 May 18, 2026
6-K Current report (foreign issuer) May 13, 2026 May 13, 2026
6-K Current report (foreign issuer) May 13, 2026 May 13, 2026
20-F Annual report (foreign issuer) Apr 29, 2026 Dec 31, 2025

Source: SEC EDGAR filings. This is company-reported data, not investment advice.